Previous 10 | Next 10 |
home / stock / tbpmf / tbpmf news
Tetra Bio-Pharma Inc. Announces Pricing of Unit Offering Canada NewsWire OTTAWA, June 24, 2019 /NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , June 24, 2019 /CNW/ - Tetra Bio-Pharma Inc . (" Tetra "...
Tetra Bio-Pharma Inc. Announces Voting Results of 2019 Annual General and Special Meeting Canada NewsWire ORLEANS, ON, June 21, 2019 ORLEANS, ON , June 21, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSX VENTURE: TBP) (OTCQB: ...
Tetra Bio-Pharma Inc. Announces Proposed Offering of Units Canada NewsWire OTTAWA, June 19, 2019 /NOT FOR DISTRIBUTION TO THE UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / OTTAWA , June 19, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc...
OTTAWA - June 18, 2019 (Investorideas.com Newswire) Tetra Natural Health, a subsidiary of Tetra Bio-Pharma ( TSX V: TBP ) ( OTCQB: TBPMF ), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) ("Spyder") to distribute the three flavors of its He...
OTTAWA, June 18, 2019 (GLOBE NEWSWIRE) -- Tetra Natural Health, a subsidiary of Tetra Bio-Pharma (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced that it has signed an exclusive agreement with Spyder Cannabis Inc. (TSX VENTURE: SPDR) (“ Spyder ”) to distribute the three flav...
U.S. granted patent protection for ophthalmic use; U.S. granted patent protection for topical delivery, increased drug solubility and abuse deterrence; U.S. FDA provides positive response on painful dry eye development program; Panag completes a Phase 3 clinical trial for...
Tetra Bio-Pharma Inc. Announces Change of Annual General Meeting Time Canada NewsWire ORLEANS, ON, June 17, 2019 ORLEANS, ON , June 17, 2019 /CNW Telbec/ - Tetra Bio-Pharma Inc . (" Tetra " or the " Corporation ") (TSXV: TBP) (OTCQB: TBPMF), a global leader in ...
OTTAWA, June 17, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., (“ Tetra ” or the “ Company ”) a leader in cannabinoid-derived drug discovery and development (TSX VENTURE:TBP) (OTCQB:TBPMF) today announced that it conducted a Type B meeting with the United Sta...
Tetra Bio-Pharma Inc. Announces Director Resignation Canada NewsWire ORLEANS, ON, June 14, 2019 ORLEANS, ON , June 14, 2019 /CNW/ - Tetra Bio-Pharma Inc. (" Tetra " or the " Corporation ") (TSXV: TBP) (OTCQB: TBPMF), a global leader in cannabinoid-based drug develo...
OTTAWA, June 11, 2019 (GLOBE NEWSWIRE) -- Panag Pharma Inc., a subsidiary of Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced completion of Panag 001, its Phase 3 clinical trial evaluating the safety and efficacy of Topical-A, now brande...
News, Short Squeeze, Breakout and More Instantly...
Tetra Bio-Pharma Inc Company Name:
TBPMF Stock Symbol:
OTCMKTS Market:
Tetra Bio-Pharma Inc Website:
(TheNewswire) Montreal – TheNewswire - August 1, 2023 – Tetra Bio-Pharma Inc. (“ Tetra ” or the “ Company ”) ( TSX:TBP ) ( OTC:TBPMF ) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development announced that...
(TheNewswire) MONTREAL, QUEBEC – TheNewswire – May 11, 2023 -- Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development, today announced it has cancelled its New Drug Subm...
(TheNewswire) Montreal, QC - TheNewswire - March 10, 2023 - Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX:TBP) (OTC:TBPMF) (FRA:JAM1) , a leader in cannabinoid-derived drug discovery and development is pleased to announce Health Canada h...